125 related articles for article (PubMed ID: 11385)
1. The inhibition by pepstatin of cathepsin D and autolysis of dystrophic muscle.
Iodice AA
Life Sci; 1976 Nov; 19(9):1351-8. PubMed ID: 11385
[No Abstract] [Full Text] [Related]
2. Cathepsins A, B, C, D and autolysis during development of breast muscle of normal and dystrophic chickens.
Iodice AA; Chin J; Perker S; Weinstock IM
Arch Biochem Biophys; 1972 Sep; 152(1):166-74. PubMed ID: 5072697
[No Abstract] [Full Text] [Related]
3. The effects of lactoyl-pepstatin and the pepsin inhibitor peptide on pig cathepsin D.
Kay J; Afting EG; Aoyagi T; Dunn BM
Biochem J; 1982 Jun; 203(3):795-7. PubMed ID: 7115318
[TBL] [Abstract][Full Text] [Related]
4. Regional brain distribution of cathepsin D activity: its inhibition in vivo following central infusion of pepstatin in the rat.
Buccafusco JJ; Goldstein BD; Greenbaum LM
Res Commun Chem Pathol Pharmacol; 1982 Apr; 36(1):157-60. PubMed ID: 7079582
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of thyroid cathepsin D activity by pepstatin.
Starling JR; Hopps BA
J Surg Res; 1980 Jan; 28(1):8-13. PubMed ID: 6153736
[No Abstract] [Full Text] [Related]
6. Specific inhibition of Triiodothyronine-induced tadpole tail-fin regression by cathepsin D-inhibitor pepstatin.
Seshimo H; Ryuzaki M; Yoshizato K
Dev Biol; 1977 Aug; 59(1):96-100. PubMed ID: 302228
[No Abstract] [Full Text] [Related]
7. Pepstatin inhibition of cathepsin D in situ and its modification of leukokinin formation: HPLC separation of fluorescamine-treated kinins.
Greenbaum LM; Sutherland JH; Narayan TK
Adv Exp Med Biol; 1983; 156 (Pt B)():783-7. PubMed ID: 6190383
[No Abstract] [Full Text] [Related]
8. Dinitrophenyl-pepstatins as active-site-directed localization reagents for cathepsin D.
Matthews IT; Decker RS; Hornebeck W; Knight CG
Biochem J; 1983 Apr; 211(1):139-47. PubMed ID: 6347185
[TBL] [Abstract][Full Text] [Related]
9. Interaction of human cathepsin D with the inhibitor pepstatin.
Knight CG; Barrett AJ
Biochem J; 1976 Apr; 155(1):117-25. PubMed ID: 938470
[TBL] [Abstract][Full Text] [Related]
10. Muscular dystrophy: inhibition of degeneration in vivo with protease inhibitors.
Stracher A; McGowan EB; Shafiq SA
Science; 1978 Apr; 200(4337):50-1. PubMed ID: 635570
[TBL] [Abstract][Full Text] [Related]
11. Biological activity of aspartic proteinase inhibitors related to pepstatin.
Gunn JM; Owens RA; Liu WS; Glover GI
Acta Biol Med Ger; 1981; 40(10-11):1547-53. PubMed ID: 6805191
[TBL] [Abstract][Full Text] [Related]
12. Delayed degeneration of dystrophic and normal muscle cell cultures treated with pepstatin, leupeptin, and antipain.
McGowan EB; Shafiq SA; Stracher A
Exp Neurol; 1976 Mar; 50(3):649-57. PubMed ID: 1253868
[No Abstract] [Full Text] [Related]
13. Effects of cathepsin B, H, and D in pectoral muscle of dystrophic chickens (line 413) of in vivo administration of E-64-c (N-[N-(L-3-transcarboxyoxirane-2-carbonyl)-L-leucyl]-3-methyl-butylamine).
Noda T; Isogai K; Katunuma N; Tarumoto Y; Ohzeki M
J Biochem; 1981 Sep; 90(3):893-6. PubMed ID: 7309707
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cathepsin D by synthetic oligopeptides.
Lin TY; Williams HR
J Biol Chem; 1979 Dec; 254(23):11875-83. PubMed ID: 500680
[No Abstract] [Full Text] [Related]
15. Altered protein synthesis and creatine kinase in breast muscle cell cultures from dystrophic chick embryos.
Ionasescu V; Ionasescu R; White D; Feld R; Cancilla P; Kaeding L; Kraus L; Stern L
J Neurol Sci; 1980 May; 46(2):157-68. PubMed ID: 7381511
[TBL] [Abstract][Full Text] [Related]
16. Treatment of mouse muscular dystrophy with the protease inhibitor pepstatin.
Schorr EE; Arnason BG; Aström KE; Darzynkiewicz Z
J Neuropathol Exp Neurol; 1978 May; 37(3):263-8. PubMed ID: 660216
[TBL] [Abstract][Full Text] [Related]
17. Effect of leupeptin on protein turnover in normal and dystrophic chicken skeletal muscle cells in culture.
Riebow JF; Young RB
Biochem Med; 1980 Jun; 23(3):316-23. PubMed ID: 7417239
[No Abstract] [Full Text] [Related]
18. Bimane-labelled pepstatin, a fluorescent probe for the subcellular location of cathepsin D.
Matthews IT; Decker RS; Knight CG
Biochem J; 1981 Dec; 199(3):611-7. PubMed ID: 7340822
[TBL] [Abstract][Full Text] [Related]
19. Interaction of dinitrophenyl-pepstatins with human cathepsin D and with anti-dinitrophenyl antibody. Development of potential reagents for the localization in vivo of active proteinases at sites of tissue injury.
Knight CG; Hornebeck W; Matthews IT; Hembry RM; Dingle JT
Biochem J; 1980 Dec; 191(3):835-43. PubMed ID: 6793037
[TBL] [Abstract][Full Text] [Related]
20. Leupeptin, a protease inhibitor, decreases protein degradation in normal and diseased muscles.
Libby P; Goldberg AL
Science; 1978 Feb; 199(4328):534-6. PubMed ID: 622552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
